Leqvio Archives -

Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for

Verve starts trials of cholesterol drug in test of base editing technique

https://pharmaphorum.com/news/verve-starts-trials-of-cholesterol-drug-in-test-of-base-editing-technique/

At its second attempt, Novartis has won FDA approval for its cholesterol lowering drug inclisiran, which can reduce

Novartis bags elusive US approval for cholesterol drug inclisiran

https://pharmaphorum.com/news/novartis-bags-elusive-us-approval-for-cholesterol-drug-inclisiran/

Novartis’ cholesterol-lowering drug Leqvio will be made available on the NHS in England and Wales, and could help

NICE backs NHS use of Novartis’ cholesterol drug Leqvio

https://pharmaphorum.com/news/nice-backs-nhs-use-of-novartis-cholesterol-drug-leqvio/

Novartis has revealed that the FDA has accepted its resubmission for cholesterol-lowering drug Leqvio – rejected unexpectedly by

Novartis eyes New Year verdict from FDA on delayed Leqvio

https://pharmaphorum.com/news/novartis-eyes-new-year-verdict-from-fda-on-delayed-leqvio/

Novartis’ near-$10 billion takeover of The Medicines Company last year was focused mainly on one asset – cholesterol-lowering

Novartis’ big bet on inclisiran nears fruition, as CHMP backs drug

https://pharmaphorum.com/news/novartis-big-bet-on-inclisiran-nears-fruition-as-chmp-backs-drug/

Leqvio